Founded in 2010, AGATSA operates in Health Tech offering the worlds smallest 12-lead ECG device, SanketLife. This key chain-sized device allows users to take medical grade ECGs anywhere and anytime, f...
Funding stage:
Corporate Round
Last funding:
04/10/2023
Total funding:
$6.79 Mn+
Revenue:
Investors
Employee count:
47
Last 90d
47
Last 90d
Web traffic:
1.99K
1.99K
Last 30d
Last 30d
Glassdoor Rating:
AGATSA: Cap Table Highlights
A snapshot of cap table and shareholder metrics
Total Shareholders19
Latest Filing Date30 March 2024- Funding Events53
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of AGATSA
As of 31 March 2024, AGATSA's equity is held by 17 shareholders, with the top three being Sun Pharma, Mayur Desai, and Rahul Rastogi.
Sun Pharma holds the largest stake in AGATSA at 21.6% as of 31 March 2024.
As of 31 March 2024, founders collectively hold 21.6% equity in AGATSA.
As of 31 March 2024, investors collectively hold 29.8% equity in AGATSA.
AGATSA's ESOP pool stands at 19.5% of total equity as of 31 March 2024.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links